These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1069 related items for PubMed ID: 26765625

  • 1. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G, Ceccarelli G, Serafino S, Giustini N, Cavallari EN, Bianchi L, Pavone P, Bellelli V, Turriziani O, Antonelli G, Stroffolini T, Vullo V.
    J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
    [Abstract] [Full Text] [Related]

  • 2. HCV coinfection does not alter the frequency of regulatory T cells or CD8+ T cell immune activation in chronically infected HIV+ Chinese subjects.
    Zhuang Y, Wei X, Li Y, Zhao K, Zhang J, Kang W, Sun Y.
    AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1044-51. PubMed ID: 22214236
    [Abstract] [Full Text] [Related]

  • 3. Higher Activation in CD4(+) T Cells But Similar Viral Control Among HIV/Hepatitis C Virus-Coinfected Patients on a Simplification Monotherapy.
    BenMarzouk-Hidalgo OJ, Torres-Cornejo A, Gutierrez-Valencia A, Ruiz-Valderas R, Viciana P, López-Cortés LF.
    AIDS Res Hum Retroviruses; 2016 Jan; 32(1):6-11. PubMed ID: 26414169
    [Abstract] [Full Text] [Related]

  • 4. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
    Al-Harthi L, Voris J, Du W, Wright D, Nowicki M, Frederick T, Landay A, Kovacs A.
    J Infect Dis; 2006 May 01; 193(9):1202-10. PubMed ID: 16586355
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients.
    Hodowanec AC, Brady KE, Gao W, Kincaid SL, Plants J, Bahk M, Landay AL, Huhn GD.
    J Acquir Immune Defic Syndr; 2013 Nov 01; 64(3):232-40. PubMed ID: 24131865
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection.
    Feuth T, Arends JE, Fransen JH, Nanlohy NM, van Erpecum KJ, Siersema PD, Hoepelman AI, van Baarle D.
    PLoS One; 2013 Nov 01; 8(3):e59302. PubMed ID: 23555014
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Causes of T lymphocyte activation in HIV-infected patients coinfected with hepatitis C virus].
    Shmagel KV, Shmagel NG, Korolevskaya LB, Saydakova EV, Chereshnev VA.
    Ter Arkh; 2016 Nov 01; 88(11):22-28. PubMed ID: 28005028
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children.
    Resino S, Galán I, Bellón JM, Navarro ML, León JA, Muñoz-Fernandez MA.
    J Clin Immunol; 2003 Jul 01; 23(4):279-89. PubMed ID: 12959220
    [Abstract] [Full Text] [Related]

  • 13. Monocyte activation in HIV/HCV coinfection correlates with cognitive impairment.
    Rempel H, Sun B, Calosing C, Abadjian L, Monto A, Pulliam L.
    PLoS One; 2013 Jul 01; 8(2):e55776. PubMed ID: 23437063
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The correlation between HLA-DR or CD38 expression in CD8(+)T cells and CD4(+)T cells count in treatment-naive HIV/AIDS patients].
    Xie J, Qiu Z, Han Y, Li Y, Song X, Li T.
    Zhonghua Nei Ke Za Zhi; 2016 Jan 01; 55(1):36-9. PubMed ID: 26796651
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.
    Dyrhol-Riise AM, Voltersvik P, Olofsson J, Asjö B.
    AIDS; 1999 Dec 03; 13(17):2365-76. PubMed ID: 10597778
    [Abstract] [Full Text] [Related]

  • 18. HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells.
    Rallón N, García M, García-Samaniego J, Rodríguez N, Cabello A, Restrepo C, Álvarez B, García R, Górgolas M, Benito JM.
    PLoS One; 2017 Dec 03; 12(3):e0173943. PubMed ID: 28323897
    [Abstract] [Full Text] [Related]

  • 19. Chronic immune activation and decreased CD4 cell counts associated with hepatitis C infection in HIV-1 natural viral suppressors.
    Sajadi MM, Pulijala R, Redfield RR, Talwani R.
    AIDS; 2012 Sep 24; 26(15):1879-84. PubMed ID: 22824629
    [Abstract] [Full Text] [Related]

  • 20. Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients.
    Najafi Fard S, Schietroma I, Corano Scheri G, Giustini N, Serafino S, Cavallari EN, Pinacchio C, De Girolamo G, Ceccarelli G, Scagnolari C, Vullo V, d'Ettorre G.
    Clin Res Hepatol Gastroenterol; 2018 Sep 24; 42(4):319-329. PubMed ID: 29279268
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 54.